BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11793443)

  • 1. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene.
    Tabor MP; van Houten VM; Kummer JA; Vosjan MJ; Vlasblom R; Snow GB; Leemans CR; Braakhuis BJ; Brakenhoff RH
    Genes Chromosomes Cancer; 2002 Feb; 33(2):168-77. PubMed ID: 11793443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The origins of multiple squamous cell carcinomas in the aerodigestive tract.
    van Oijen MG; Leppers Vd Straat FG; Tilanus MG; Slootweg PJ
    Cancer; 2000 Feb; 88(4):884-93. PubMed ID: 10679659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
    Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
    Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of pulmonary carcinoma following head and neck cancer by genetic analysis.
    Geurts TW; van Velthuysen ML; Broekman F; van Huysduynen TH; van den Brekel MW; van Zandwijk N; van Tinteren H; Nederlof P; Balm AJ; Brakenhoff RH
    Clin Cancer Res; 2009 Feb; 15(3):980-5. PubMed ID: 19188169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
    el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
    Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival.
    Field JK; Kiaris H; Risk JM; Tsiriyotis C; Adamson R; Zoumpourlis V; Rowley H; Taylor K; Whittaker J; Howard P
    Br J Cancer; 1995 Nov; 72(5):1180-8. PubMed ID: 7577465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.
    Ahomadegbe JC; Barrois M; Fogel S; Le Bihan ML; Douc-Rasy S; Duvillard P; Armand JP; Riou G
    Oncogene; 1995 Mar; 10(6):1217-27. PubMed ID: 7700647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases.
    Tjebbes GW; Leppers vd Straat FG; Tilanus MG; Hordijk GJ; Slootweg PJ
    Oral Oncol; 1999 Jul; 35(4):384-9. PubMed ID: 10645403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
    Leong PP; Rezai B; Koch WM; Reed A; Eisele D; Lee DJ; Sidransky D; Jen J; Westra WH
    J Natl Cancer Inst; 1998 Jul; 90(13):972-7. PubMed ID: 9665144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma.
    Borkosky SS; Gunduz M; Nagatsuka H; Beder LB; Gunduz E; Ali MA; Rodriguez AP; Cilek MZ; Tominaga S; Yamanaka N; Shimizu K; Nagai N
    J Cancer Res Clin Oncol; 2009 May; 135(5):703-13. PubMed ID: 18998165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and clinicopathologic comparisons of head and neck squamous carcinoma variants: common and distinctive features of biological significance.
    Choi HR; Roberts DB; Johnigan RH; Sturgis EM; Rosenthal DI; Weber RS; Luna MA; Batsakis JG; El-Naggar AK
    Am J Surg Pathol; 2004 Oct; 28(10):1299-310. PubMed ID: 15371945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
    Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
    Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer.
    Takebayashi S; Hickson A; Ogawa T; Jung KY; Mineta H; Ueda Y; Grénman R; Fisher SG; Carey TE
    Genes Chromosomes Cancer; 2004 Oct; 41(2):145-54. PubMed ID: 15287027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that loss of chromosome 18q is associated with tumor progression.
    Frank CJ; McClatchey KD; Devaney KO; Carey TE
    Cancer Res; 1997 Mar; 57(5):824-7. PubMed ID: 9041179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
    Leng K; Schlien S; Bosch FX
    J Oral Pathol Med; 2006 Jan; 35(1):19-24. PubMed ID: 16393249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral genetic heterogeneity in primary head and neck squamous carcinoma using microsatellite markers.
    el-Naggar AK; Hurr K; Luna MA; Goepfert H; Hong WK; Batsakis JG
    Diagn Mol Pathol; 1997 Dec; 6(6):305-8. PubMed ID: 9559289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
    Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.